26031-Renal Cancer-NA-150

Renal Cancer

A Phase 2, Open-label Clinical Study to Evaluate the Safety and Efficacy of MK-2010 as Monotherapy and in Combination (MK-2010-002)

  • Details

ClinicalTrials.gov ID: NCT07793942
Diagnosis Type: NA
USOR Number:

  • Address


,
P:

Search by practice name, trial titles, indicators and specific disease types.